Inhibition of the STING signaling pathway has become a new target in the fight against musculoskeletal disorders, as elimination of senescent cells or inhibition of the production of pro-inflammatory secretory proteins delays the onset or inhibits the severity of many chronic diseases. The gene discussed is STING1; the disease is musculoskeletal system disorder.